361 related articles for article (PubMed ID: 21600888)
1. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation.
Joh EH; Lee IA; Jung IH; Kim DH
Biochem Pharmacol; 2011 Aug; 82(3):278-86. PubMed ID: 21600888
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages.
Lee IA; Hyam SR; Jang SE; Han MJ; Kim DH
J Agric Food Chem; 2012 Sep; 60(38):9595-602. PubMed ID: 22849695
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of ginsenoside Rg1 and its metabolites ginsenoside Rh1 and 20(S)-protopanaxatriol in mice with TNBS-induced colitis.
Lee SY; Jeong JJ; Eun SH; Kim DH
Eur J Pharmacol; 2015 Sep; 762():333-43. PubMed ID: 26054809
[TBL] [Abstract][Full Text] [Related]
4. Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-κB and MAPK pathways.
Jeong JJ; Jang SE; Hyam SR; Han MJ; Kim DH
Eur J Pharmacol; 2014 Oct; 740():652-61. PubMed ID: 24972244
[TBL] [Abstract][Full Text] [Related]
5. Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages.
Jang SE; Jeong JJ; Hyam SR; Han MJ; Kim DH
J Agric Food Chem; 2014 Oct; 62(40):9711-21. PubMed ID: 25213465
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages.
Kim TW; Joh EH; Kim B; Kim DH
Int Immunopharmacol; 2012 Jan; 12(1):110-6. PubMed ID: 22107725
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effects of vina-ginsenoside R2 and majonoside R2 isolated from Panax vietnamensis and their metabolites in lipopolysaccharide-stimulated macrophages.
Jeong JJ; Van Le TH; Lee SY; Eun SH; Nguyen MD; Park JH; Kim DH
Int Immunopharmacol; 2015 Sep; 28(1):700-6. PubMed ID: 26256699
[TBL] [Abstract][Full Text] [Related]
8. Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways.
Joh EH; Kim DH
Br J Pharmacol; 2011 Apr; 162(8):1731-42. PubMed ID: 21198552
[TBL] [Abstract][Full Text] [Related]
9. Echinocystic acid, a metabolite of lancemaside A, inhibits TNBS-induced colitis in mice.
Hyam SR; Jang SE; Jeong JJ; Joh EH; Han MJ; Kim DH
Int Immunopharmacol; 2013 Feb; 15(2):433-41. PubMed ID: 23352442
[TBL] [Abstract][Full Text] [Related]
10. Soyasaponin Ab ameliorates colitis by inhibiting the binding of lipopolysaccharide (LPS) to Toll-like receptor (TLR)4 on macrophages.
Lee IA; Park YJ; Joh EH; Kim DH
J Agric Food Chem; 2011 Dec; 59(24):13165-72. PubMed ID: 22060784
[TBL] [Abstract][Full Text] [Related]
11. Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing M1 macrophages to M2-like macrophages.
Hyam SR; Lee IA; Gu W; Kim KA; Jeong JJ; Jang SE; Han MJ; Kim DH
Eur J Pharmacol; 2013 May; 708(1-3):21-9. PubMed ID: 23375938
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages.
Jang SE; Han MJ; Kim SY; Kim DH
Int Immunopharmacol; 2014 Jul; 21(1):186-92. PubMed ID: 24815859
[TBL] [Abstract][Full Text] [Related]
13. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation.
Lee IA; Hyun YJ; Kim DH
Eur J Pharmacol; 2010 Dec; 648(1-3):162-70. PubMed ID: 20828550
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide.
Park EK; Shin YW; Lee HU; Kim SS; Lee YC; Lee BY; Kim DH
Biol Pharm Bull; 2005 Apr; 28(4):652-6. PubMed ID: 15802804
[TBL] [Abstract][Full Text] [Related]
15. Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury.
Lee HU; Bae EA; Han MJ; Kim NJ; Kim DH
Liver Int; 2005 Oct; 25(5):1069-73. PubMed ID: 16162168
[TBL] [Abstract][Full Text] [Related]
16. Ocotillol, a Majonoside R2 Metabolite, Ameliorates 2,4,6-Trinitrobenzenesulfonic Acid-Induced Colitis in Mice by Restoring the Balance of Th17/Treg Cells.
Lee SY; Jeong JJ; Le TH; Eun SH; Nguyen MD; Park JH; Kim DH
J Agric Food Chem; 2015 Aug; 63(31):7024-31. PubMed ID: 26194345
[TBL] [Abstract][Full Text] [Related]
17. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance.
Lim SM; Jeong JJ; Kang GD; Kim KA; Choi HS; Kim DH
Int Immunopharmacol; 2015 Apr; 25(2):493-503. PubMed ID: 25698557
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-κB activation.
Li J; Zhong W; Wang W; Hu S; Yuan J; Zhang B; Hu T; Song G
PLoS One; 2014; 9(2):e87810. PubMed ID: 24504372
[TBL] [Abstract][Full Text] [Related]
19. Lancemaside A ameliorates colitis by inhibiting NF-kappaB activation in TNBS-induced colitis mice.
Joh EH; Lee IA; Han SJ; Chae S; Kim DH
Int J Colorectal Dis; 2010 May; 25(5):545-51. PubMed ID: 19956958
[TBL] [Abstract][Full Text] [Related]
20. 4-Methoxylonchocarpin attenuates inflammation by inhibiting lipopolysaccharide binding to Toll-like receptor of macrophages and M1 macrophage polarization.
Jang HM; Kang GD; Van Le TK; Lim SM; Jang DS; Kim DH
Int Immunopharmacol; 2017 Apr; 45():90-97. PubMed ID: 28189973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]